Acurx Pharmaceuticals (ACXP) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-2.6
-1.78
-0.96
-0.15

Details

Expected EPS
-2.6
Actual EPS
-2.2
Surprise EPS
0.4
Surprise Percent
+15.38%

Description

Acurx Pharmaceuticals (ACXP) has reported earnings of -2.2 per share for Q2 2025.

0 Comments

Share your thoughts